What a Dendritic Cell Migration Assay Delivers
Dendritic cell migration assays quantify how dendritic cells move toward a chemoattractant gradient in a controlled in vitro setting. They are used in preclinical immunology and vaccine programs to assess mobilization and chemotactic response as part of a broader characterization package. Our service covers assay design, dendritic cell source selection and preparation, maturation or mobilization steps where required, transwell chemotaxis setup, and quantification of migrated cells by flow cytometry or imaging. Each project is scoped individually, with appropriate controls and a custom report that includes methods and results suitable for internal decision-making and program documentation.
Parallel dendritic cell maturation and antigen presentation assays can place migration findings in the context of DC activation.
Assay Capabilities and Scoped Options
Human or Mouse Dendritic Cells
Assays can be designed around primary or differentiated dendritic cells from human or mouse sources, with donor and sample sourcing discussed during project scoping.
Transwell Chemotaxis Workflow
Directed migration is evaluated in a transwell format with a chemoattractant gradient, including no-gradient controls to support interpretation of migration-specific responses.
Maturation and Mobilization Steps
Where the program requires it, dendritic cell maturation or mobilization steps are incorporated before migration, with stimulation conditions agreed during assay design.
Flow Cytometry or Imaging Readouts
Migrated cells are quantified by flow cytometry or imaging, depending on cell numbers, labeling strategy, and the readout format selected for the study.
How a Dendritic Cell Migration Project Runs
Typical Deliverables
| Deliverable | What It Covers |
|---|---|
| Assay design summary | A concise record of the agreed dendritic cell source, chemoattractant gradient format, transwell setup, and endpoint readout, finalized during project scoping. |
| Migration dataset | Quantified migrated dendritic cell counts from flow cytometry or imaging readouts, organized by condition and replicate for review. |
| Migration index analysis | Calculated migration index values comparing directed migration against no-gradient and background controls, with the calculation basis documented. |
| Control performance record | A summary of the control readouts collected in the study, covering the no-gradient and background controls applied and how they performed, finalized against the agreed assay design. |
| Methods and results report | A custom report describing the workflow, assay conditions, analysis approach, and observed migration readouts, formatted for inclusion in preclinical immunology program documentation. |
Why Choose Our Dendritic Cell Migration Assay Services
Dendritic cell–focused assay design
Assays are built around dendritic cell biology rather than generic migration formats. Human or mouse dendritic cell sources are selected during scoping, and maturation or mobilization steps are incorporated where the study question calls for them.
Migration can be quantified by flow cytometry or imaging depending on the cell numbers and endpoints involved. Chemoattractant choice, gradient format, and timepoints are customized to your program rather than fixed to a single template.
Controls and analysis built in
No-gradient and background controls are planned as part of the assay design, and results are reported with migration index calculations so that directed movement is presented alongside baseline migration. Reporting is customized with methods and results suitable for preclinical immunology programs.
Further Reading
Research reference
1. Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
Nature Communications. 2024. DOI: 10.1038/s41467-024-44787-1.
View articleDiscuss Your Dendritic Cell Migration Assay
Share your dendritic cell source, chemoattractant of interest, and preferred readout, and our team will outline a scoped assay design with controls, timeline, and reporting format. Exploratory and screening-oriented studies can both be accommodated, with donor selection and sample sourcing discussed during design.
Human DC projects can incorporate PBMC isolation and immune cell preparation where donor-derived cell preparation is required.